Lakewood-Amedex names USC professor to chair diabetic foot ulcer trial

June 25, 2026 8:02 AM

Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) has appointed David G. Armstrong, DPM, M.D., Ph.D., as Study Chair for its Phase 2a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found